| Product Code: ETC6513608 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, Brazil`s import shipments of pregabalin continued to be dominated by top exporting countries such as China, UK, India, Japan, and Metropolitan France, reflecting a high concentration level indicated by the Herfindahl-Hirschman Index (HHI). Despite a modest Compound Annual Growth Rate (CAGR) of 1.39% from 2020 to 2024, the growth rate experienced a decline of -33.34% from 2023 to 2024. This data suggests a dynamic market environment for pregabalin imports in Brazil, with fluctuations in growth rates potentially influenced by various factors impacting the pharmaceutical industry and global trade dynamics.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Brazil Pregabalin Market Overview |
3.1 Brazil Country Macro Economic Indicators |
3.2 Brazil Pregabalin Market Revenues & Volume, 2021 & 2031F |
3.3 Brazil Pregabalin Market - Industry Life Cycle |
3.4 Brazil Pregabalin Market - Porter's Five Forces |
3.5 Brazil Pregabalin Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.6 Brazil Pregabalin Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.7 Brazil Pregabalin Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Brazil Pregabalin Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic pain conditions in Brazil |
4.2.2 Growing awareness and acceptance of pregabalin as an effective treatment for neuropathic pain |
4.2.3 Rise in healthcare expenditure and improved access to healthcare services in Brazil |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for the approval and sale of pharmaceutical products in Brazil |
4.3.2 Pricing pressures from generic alternatives impacting the profitability of pregabalin manufacturers |
5 Brazil Pregabalin Market Trends |
6 Brazil Pregabalin Market, By Types |
6.1 Brazil Pregabalin Market, By Application |
6.1.1 Overview and Analysis |
6.1.2 Brazil Pregabalin Market Revenues & Volume, By Application, 2021- 2031F |
6.1.3 Brazil Pregabalin Market Revenues & Volume, By Epilepsy, 2021- 2031F |
6.1.4 Brazil Pregabalin Market Revenues & Volume, By Neuropathic Pain, 2021- 2031F |
6.1.5 Brazil Pregabalin Market Revenues & Volume, By Anxiety Disorder, 2021- 2031F |
6.1.6 Brazil Pregabalin Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Brazil Pregabalin Market, By Drug Class |
6.2.1 Overview and Analysis |
6.2.2 Brazil Pregabalin Market Revenues & Volume, By Fibromyalgia Agents, 2021- 2031F |
6.2.3 Brazil Pregabalin Market Revenues & Volume, By Anticonvulsants, 2021- 2031F |
6.2.4 Brazil Pregabalin Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Brazil Pregabalin Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Brazil Pregabalin Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.3.3 Brazil Pregabalin Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.3.4 Brazil Pregabalin Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.3.5 Brazil Pregabalin Market Revenues & Volume, By Others, 2021- 2031F |
7 Brazil Pregabalin Market Import-Export Trade Statistics |
7.1 Brazil Pregabalin Market Export to Major Countries |
7.2 Brazil Pregabalin Market Imports from Major Countries |
8 Brazil Pregabalin Market Key Performance Indicators |
8.1 Prescription rate of pregabalin by healthcare providers in Brazil |
8.2 Patient adherence and persistence rate for pregabalin treatment |
8.3 Number of clinical trials and research studies conducted on pregabalin efficacy and safety in Brazil |
9 Brazil Pregabalin Market - Opportunity Assessment |
9.1 Brazil Pregabalin Market Opportunity Assessment, By Application, 2021 & 2031F |
9.2 Brazil Pregabalin Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.3 Brazil Pregabalin Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Brazil Pregabalin Market - Competitive Landscape |
10.1 Brazil Pregabalin Market Revenue Share, By Companies, 2024 |
10.2 Brazil Pregabalin Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here